CVS' Aetna sues drug manufacturers for price-fixing and market allocation scheme. The subsidiary seeks damages and ...

The national group representing generic drug and biosimilar manufacturers is looking to replicate its success challenging ...

Oncology drugs tend to “percolate to the top” of shortage lists that prioritize drugs of concern, said expert.

New Jersey-based pharmaceutical company UCB has sued to protect its patents for a Parkinson’s drug after an India-based ...

The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.

The US Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals), ...

The legislative rush provided another example of state lawmakers struggling to reach consensus on significant policy matters, ...

FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes ...

The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...

Patients would pay no more than $25 for certain name-brand medications to treat chronic illnesses, including insulin for ...

The Company has been granted Competitive Generic Therapy designation, which allows for 180 days of marketing exclusivity.